Compound and pharmaceutical composition containing same for treating or preventing neural damage, neural disease, or developmental disorder through promoting proliferation, differentiation, and/or regeneration of neural cells
US12404255B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 25, 2020 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Jan 10, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound of formula 1 and a pharmaceutical composition containing same. This compound may be useful as: a therapeutic agent for degenerative brain diseases including dementia or cranial nerve diseases and developmental disorders caused by neural cell damage, various degenerative neural diseases, ischemic nerve diseases, or neural damage diseases; a learning ability-improving agent; and a cognitive function-improving agent. [Formula 1] in formula 1 above, B represents a part derived from retinoic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.